Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
April 17, 2024 16:05 ET
|
Vigil Neuroscience, Inc.
- Findings from ILLUMINATE Natural History Study show that MRI and fluid biomarkers are emerging as key measures of ALSP pathophysiology - - Positive interim IGNITE Phase 2 data demonstrating...
Creyos Health Announces Addition of Dementia Screening, Testing, and Care Planning to its Online Platform
April 09, 2024 08:00 ET
|
Creyos
Toronto, Canada, April 09, 2024 (GLOBE NEWSWIRE) -- Creyos Health, a pioneering healthcare technology company dedicated to objective brain health measurement, has unveiled an end-to-end online...
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 26, 2024 07:05 ET
|
Vigil Neuroscience, Inc.
– Reported positive interim data from Phase 2 IGNITE proof-of-concept clinical trial evaluating iluzanebart (VGL101) for treatment of ALSP – – Enrollment for IGNITE trial completed with 20 patients...
Longeveron Reports Year-End 2023 Results and Provides Corporate Update
February 27, 2024 16:05 ET
|
Longeveron
Company Announces 2024 Strategic Priorities Focused on Advancement of Lomecel-B™ in Hypoplastic Left Heart Syndrome ELPIS II Phase 2 Trial of Lomecel-B™ in HLHS Continues Enrollment; Completion of...
The PHI Foundation presents Sonia Boyce, Rajni Perera and Marigold Santos from May 3 to September 8, 2024
February 20, 2024 14:27 ET
|
PHI
Montreal, Quebec, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Sonia Boyce: FEELING HER WAYCurated by: Cheryl SimMaking its North American debut, FEELING HER WAY, which was awarded the prestigious Golden...
Three-part public art exhibition launches in downtown Toronto’s Entertainment District
February 16, 2024 07:17 ET
|
Fengate Asset Management
LiUNA, Fengate, and Black Artists’ Networks in Dialogue are proud to launch a three-part public art exhibit dubbed BAND Offsite – 355 Adelaide in Toronto.
Touchplan’s Management Analytics Delivers Collaborative Digital Decisioning for Better Construction Planning
February 15, 2024 09:00 ET
|
Touchplan (MOCA Systems)
MOCA Systems, Inc. released Management Analytics, an expansion of the analytics capabilities in its Touchplan real-time real-time construction platform.
Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Investigation Product Lomecel-B™
January 29, 2024 08:00 ET
|
Longeveron
MIAMI, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and...
A Big Year for Studies on Brain Training
January 22, 2024 08:00 ET
|
Posit Science
SAN FRANCISCO, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Last year was another banner year for research showing the effectiveness of computerized brain training, according to Posit Science, the maker of the...
Longeveron Announces Additional Positive Clinical Data and Imaging Biomarker Results from the CLEAR MIND Phase 2a Trial of Lomecel-B™ in the Treatment of Mild Alzheimer’s Disease
December 20, 2023 08:00 ET
|
Longeveron
New clinical data showed that Lomecel-B™ improved cognitive function in multiple measures in a dose-response fashion Caregiver ratings documented improved quality of life in Lomecel-B™ treated...